ARQ 197: New Clinical Trial for Patients with Alveolar Soft Part Sarcoma
Update on the ARQ 197 Clinical Trial (November 23): The new clinical trial (read below)
Yosef
November 6, 2007
Update on the ARQ 197 Clinical Trial (November 23): The new clinical trial (read below)
Dear ASPS community. As you probably know, the GVAX cancer vaccine clinical trial has been
A collaboration between scientists from The Memorial Sloan-Kettering Cancer Center in New York, Dana-Farber Cancer
1. Phase II Study of Sorafenib in Patients With Advanced Soft Tissue Sarcomas 2. Sorafenib
October 11, 2006 The clinical trial “GVAX Cancer Vaccine” started in January 2006 and enrollment